LinkMed

The LinkMed portfolio consists of a number of life science companies, several of which are nearing the commercialization phase, while others are already selling their products or services. Between them, these companies account for more than 50 different projects in a wide range of therapeutic areas – from HIV and cancer to eye disease and allergies.

COMPANIES IN SEVERAL SECTORS
LinkMed has created a portfolio of twelve companies, four in drug development and biotechnology and eight in diagnostics and medical technology

MANY COMPANIES, LOWER RISKS
By investing in several companies, we spread risks and reduce our exposure to the development in individual projects. Our goal is to continually develop and manage between 15 and 20 portfolio companies. Therefore, we plan to invest in several new companies in the coming years.

Instruments for spinal surgery

Operations: OrtoWay (previously called Ortoviva) develops instruments for spinal surgery that facilitate the insertion of artificial discs. The company has developed three proto-types, an instrument that holds adjacent vertebrae apart, a seal for attaching the artificial disc and a bone cement administrator.

Sektor: Diagnostics and medical technology

Therapeutic area: Orthopedics

CEO: Stan Mikulowski

Chairman: Sven Gustafsson

Venture manager: Stan Mikulowski

Ownership stake: 61.7%

Address: OrtoWay AB Box 7710
Drottninggatan 33
SE- 103 95 Stockholm
Sweden

www.ortoway.com

Back